MEDROL Safety Questions, MEDROL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about MEDROL. Our extensive database of MEDROL adverse events and MEDROL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about MEDROL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




MEDROL Safety Reports

Total MEDROL reports: 50.
MEDROL FDA safety alerts: No.
Reported deaths: 3    Reported hospitalizations: 31.
Take MEDROL Side Effects Survey or Share Your MEDROL Story. MEDROL Usage.

Pharmacist from JAPAN reported MEDROL problem on Jan 05, 2007. Female patient, 55 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: anorexia, haematochezia, nausea. MEDROL dosage: DAILY DOSE:12MG. During the same period patient was treated with RINLAXER, NEUROTROPIN, VOLTAREN, CYANOCOBALAMIN, MYONAL. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on Jan 04, 2007. Male patient, 56 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: cataract, cushing's syndrome, glaucoma, hypokalaemia, intestinal perforation, large intestine perforation, osteoporosis, small intestinal perforation. MEDROL dosage: DAILY DOSE:2MG. During the same period patient was treated with DIFFU K, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MEDROL problem on Jan 23, 2007. Female patient, weighting 188.9 lb, was diagnosed with autoimmune thyroiditis, adrenal insufficiency, metal poisoning and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, lip swelling, oedema mouth, sensation of pressure, swelling face. MEDROL dosage: unknown. During the same period patient was treated with GARLIC, THYROID. Patient recovered.

MEDROL problem was reported by a Physician from ITALY on Feb 14, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. MEDROL dosage: DAILY DOSE:4MG. During the same period patient was treated with ETANERCEPT, METHOTREXATE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on Feb 12, 2007. Female patient, 47 years of age, was diagnosed with bronchitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. MEDROL dosage: unknown. During the same period patient was treated with SYMBICORT, CLARITHROMYCIN, CETIRIZINE, PARACETAMOL, TIOTROPIUM. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on Feb 12, 2007. Male patient, 56 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: intestinal perforation. MEDROL dosage: DAILY DOSE:2MG. During the same period patient was treated with DIFFU K, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on Feb 20, 2007. Male patient, 56 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: intestinal perforation. MEDROL dosage: DAILY DOSE:2MG. During the same period patient was treated with DIFFU K, REMICADE, METHOTREXATE. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on Feb 27, 2007. Female patient, 25 years of age, weighting 121.3 lb, was diagnosed with tonsillitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: colitis. MEDROL dosage: unknown. During the same period patient was treated with PYOSTACINE, LEVONORGESTREL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MEDROL problem on Mar 07, 2007. Female patient, 63 years of age, was diagnosed with immunosuppression and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, pancytopenia. MEDROL dosage: unknown. During the same period patient was treated with NEORAL, CELLCEPT. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on Mar 13, 2007. Female patient, 17 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: breast enlargement, fibroadenoma of breast, kidney transplant rejection. MEDROL dosage: unknown. During the same period patient was treated with SANDIMMUNE, PROGRAF, IMURAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MEDROL problem on Mar 16, 2007. Female patient, 63 years of age, was diagnosed with immunosuppression and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, pancytopenia. MEDROL dosage: unknown. During the same period patient was treated with NEORAL, CELLCEPT. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Health Professional from UNITED STATES on Sept 21, 2006. Female patient was diagnosed with arthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: muscle atrophy, skin discolouration, unevaluable event. MEDROL dosage: 4 MG (4 MG,1 IN 1 D). Patient recovered.

Consumer or non-health professional from JAPAN reported MEDROL problem on Mar 16, 2007. Female patient, 53 years of age, weighting 122.6 lb, was diagnosed with immunosuppression and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: pneumonitis cryptococcal. MEDROL dosage: DAILY DOSE:4MG. During the same period patient was treated with TACROLIMUS. Patient recovered.

MEDROL problem was reported by a Physician from JAPAN on Apr 04, 2007. Female patient, 40 years of age, was diagnosed with asthma and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: chorioretinopathy. MEDROL dosage: DAILY DOSE:20MG. During the same period patient was treated with RINDERON. Patient recovered.

Physician from CHINA reported MEDROL problem on Apr 09, 2007. Male patient, 25 years of age, was diagnosed with nephrotic syndrome and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: bone pain, dyspnoea, hypersensitivity, steroid withdrawal syndrome. MEDROL dosage: unknown. Patient recovered.

MEDROL problem was reported by a Physician from GREECE on Apr 11, 2007. Male patient, 60 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: peripheral motor neuropathy. MEDROL dosage: unknown. During the same period patient was treated with CAELYX, ONCOVIN. Patient recovered.

Physician from JAPAN reported MEDROL problem on Apr 11, 2007. Female patient, 40 years of age, was diagnosed with asthma and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: asthma, chorioretinopathy, mental disorder, nasopharyngitis. MEDROL dosage: DAILY DOSE:20MG. During the same period patient was treated with RINDERON, MEIACT, SUCRALFATE, MUCODYNE, QVAR, SPIRIVA, MONTELUKAST, UNIPHYL. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from INDIA on Apr 27, 2007. Female patient, 30 years of age, was diagnosed with polyp and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dyspepsia, gastritis, vomiting. MEDROL dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from FRANCE reported MEDROL problem on May 15, 2007. Female patient, weighting 112.4 lb, was diagnosed with renal pain, pyelonephritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, gait disturbance, myalgia. MEDROL dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, AMOXICILLIN. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on May 22, 2007. Female patient, 47 years of age, was diagnosed with bronchitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. MEDROL dosage: unknown. During the same period patient was treated with SYMBICORT, CLARITHROMYCIN, CETIRIZINE, PARACETAMOL, TIOTROPIUM. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on June 26, 2006. Female patient, 61 years of age, was diagnosed with ill-defined disorder and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: cheilitis, conjunctivitis, face oedema, palatal disorder, purpura, rash maculo-papular. MEDROL dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, ACETAMINOPHEN, URABNYL, ZOLPIDEM TARTRATE, LAMICTAL. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from BELGIUM on July 12, 2006. Female patient was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. MEDROL dosage: 64 MG (32 MG, 2 IN 1 D), ORAL. During the same period patient was treated with REPARIL, BEFACTTE. Patient recovered.

Physician from FRANCE reported MEDROL problem on July 25, 2006. Female patient, 90 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: erosive duodenitis, gastrointestinal haemorrhage, hypokalaemia, international normalised ratio increased, lower gastrointestinal haemorrhage, upper gastrointestinal haemorrhage. MEDROL dosage: 4 MG (4 MG, 1 D), ORAL. During the same period patient was treated with SINTROM. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from FRANCE on Aug 09, 2006. Male patient, 58 years of age, weighting 183.0 lb, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary cyst, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic steatosis. MEDROL dosage: 60 MG (60 MG, 1 IN 1 D) ORAL. During the same period patient was treated with CEFTRIAXONE, ACYCLOVIR, VANCOMYCIN, NEFOPAM, ENOXAPARIN, ACETAMINOPHEN, PHENYTOIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MEDROL problem on July 19, 2006. Male patient, 64 years of age, was diagnosed with renal transplant and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, chronic allograft nephropathy, crepitations, dyspnoea, haemodialysis, interstitial lung disease, oedema peripheral, pneumonia legionella, pyrexia. MEDROL dosage: 4 MG/D. During the same period patient was treated with CELLCEPT, NEORAL, MIZORIBINE, LYMPHOGLOBULINE. Patient was hospitalized. Patient died on 01/31/2006.

MEDROL problem was reported by a Physician from INDIA on Aug 28, 2006. Male patient was diagnosed with arthralgia and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. MEDROL dosage: 16 MG (8 MG, 2 IN 1 D) ORAL. During the same period patient was treated with MAGNEX, GEFARNATE. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on Sept 04, 2006. Male patient, 50 years of age, weighting 189.6 lb, was diagnosed with oligodendroglioma and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: inflammation, lymphopenia, pneumonia. MEDROL dosage: 32 MG (16 MG, 2 IN 1 D), ORAL. During the same period patient was treated with TEMOZOLOMIDE, PROPRANOLOL, POTASSIUM CHLORIDE, TRILEPTAL, OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from INDIA on Sept 06, 2006. Male patient was diagnosed with arthralgia, pyrexia and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, rash. MEDROL dosage: 16 MG (8 MG, 2 IN 1 D), ORAL. During the same period patient was treated with MAGNEX, GEFARNATE. Patient recovered.

Physician from INDIA reported MEDROL problem on Sept 11, 2006. Male patient was diagnosed with arthralgia, pyrexia and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, rash. MEDROL dosage: 16 MG (8 MG,2 IN 1 D), ORAL. During the same period patient was treated with MAGNEX, GEFARNATE. Patient recovered.

MEDROL problem was reported by a Pharmacist from JAPAN on Aug 30, 2006. Male patient was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: polyuria. MEDROL dosage: 4 MG, ORAL. During the same period patient was treated with TACROLIMUS. Patient recovered.

Physician from FRANCE reported MEDROL problem on Sept 21, 2006. Female patient was diagnosed with breast neoplasm and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. MEDROL dosage: 200 MG (50 MG, 4 IN 1 D);. During the same period patient was treated with PIOGLITAZONE, DOCETAXEL, ONDANSETRON, METHYLPREDNISOLONE HEMISUCCINATE, ANASTROZOLE. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from INDIA on Oct 14, 2006. Male patient was diagnosed with arthralgia, pyrexia, cough and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, rash. MEDROL dosage: 16 MG (8 MG, 2 IN 1 D), ORAL. During the same period patient was treated with MAGNEX, GEFARNATE. Patient recovered.

Physician from AUSTRIA reported MEDROL problem on Oct 24, 2006. Male patient, 51 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diverticulitis. MEDROL dosage: unknown. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from NETHERLANDS on Nov 09, 2006. Male patient, 51 years of age, weighting 215.2 lb, was diagnosed with multiple sclerosis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: diverticulitis. MEDROL dosage: 500 MG (500 MG, DAILY), ORAL. During the same period patient was treated with AMITRIPTYLINE, SIMVASTATIN, LOSEC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MEDROL problem on Nov 06, 2006. Female patient, 61 years of age, weighting 165.0 lb, was diagnosed with osteoarthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dizziness. MEDROL dosage: (80 MG). Patient recovered.

MEDROL problem was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 62 years of age, weighting 110.2 lb, was diagnosed with asthma and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial hyperreactivity, c-reactive protein increased, chronic obstructive pulmonary disease, duodenal ulcer, oedema peripheral, phlebotomus fever, pyrexia, respiratory disorder. MEDROL dosage: unknown. During the same period patient was treated with AMINOPHYLLIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MEDROL problem on Nov 18, 2006. Female patient, 61 years of age, weighting 165.0 lb, was diagnosed with osteoarthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: abasia, blood pressure decreased, dizziness, dysgraphia, speech disorder. MEDROL dosage: 80 MG. During the same period patient was treated with DIOVAN HCT. Patient recovered.

MEDROL problem was reported by a Pharmacist from JAPAN on Oct 16, 2006. Male patient, 69 years of age, was diagnosed with rheumatoid arthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, pneumonia. MEDROL dosage: unknown. During the same period patient was treated with AZULFIDINE EN, METHOTREXATE, ETODOLAC. Patient recovered.

Health Professional from UNITED STATES reported MEDROL problem on Dec 12, 2006. Female patient, 38 years of age, weighting 169.0 lb, was diagnosed with dermatitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: convulsion. MEDROL dosage: unknown. During the same period patient was treated with NYSTATIN, TRIAMICINOLONE. Patient recovered.

MEDROL problem was reported by a Health Professional from FRANCE on Dec 18, 2006. Female patient, 71 years of age, was diagnosed with bronchitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: back pain, international normalised ratio increased, muscle haemorrhage. MEDROL dosage: unknown. During the same period patient was treated with FLUINDIONE, TELITHROMYCIN, AMBROXOL HYDROCHLORIDE, CODEINE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on Dec 13, 2006. Female patient, 25 years of age, weighting 121.3 lb, was diagnosed with tonsillitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, rectal haemorrhage. MEDROL dosage: unknown. During the same period patient was treated with PYOSTACINE, LEVONORGESTREL. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from UNITED STATES on June 29, 2007. Male patient, weighting 158.1 lb, was diagnosed with tendonitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, fluid retention, gynaecomastia, swelling. MEDROL dosage: unknown. During the same period patient was treated with VITAMIN. Patient recovered.

Health Professional from FRANCE reported MEDROL problem on July 02, 2007. Female patient, 56 years of age, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pneumonia. MEDROL dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Consumer or non-health professional from GREECE on July 04, 2007. Female patient, child 11 years of age, was diagnosed with encephalitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: asthenia, exophthalmos, gait disturbance, pyrexia. MEDROL dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient was hospitalized. Patient died on 09/01/2006.

Consumer or non-health professional from FRANCE reported MEDROL problem on Aug 22, 2007. Female patient, weighting 218.3 lb, was diagnosed with polyarthritis, hypertension, diabetes mellitus, arrhythmia and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: arthralgia, chronic obstructive pulmonary disease, lipomatosis, paraesthesia. MEDROL dosage: unknown. During the same period patient was treated with ALDACTAZINE, DIAMICRON, CORDARONE. Patient recovered.

MEDROL problem was reported by a Pharmacist from FRANCE on Aug 24, 2007. Female patient, weighting 112.4 lb, was diagnosed with renal pain, pyelonephritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, gait disturbance, myalgia. MEDROL dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Health Professional from GREECE reported MEDROL problem on Aug 29, 2007. Female patient, 58 years of age, weighting 124.6 lb, was diagnosed with rheumatoid arthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: pneumonia legionella. MEDROL dosage: unknown. During the same period patient was treated with HUMIRA. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Physician from BELGIUM on Aug 30, 2007. Male patient, weighting 121.3 lb, was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: pancreatitis chronic. MEDROL dosage: unknown. During the same period patient was treated with SELECTOL, RYTHMOL, PLAVIX, CHOLEMED, COVERSYL. Patient was hospitalized. Patient died on 05/01/2007.

Physician from GREECE reported MEDROL problem on Sept 04, 2007. Female patient, 58 years of age, weighting 124.6 lb, was diagnosed with rheumatoid arthritis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: pneumonia legionella. MEDROL dosage: unknown. During the same period patient was treated with HUMIRA. Patient was hospitalized. Patient recovered.

MEDROL problem was reported by a Consumer or non-health professional from FRANCE on Aug 26, 1997. Male patient was diagnosed with brain oedema, gastric ulcer, abdominal pain, convulsion and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, peritonitis. MEDROL dosage: DAILY DOSE:32MG. During the same period patient was treated with IRINOTECAN, CYTOTEC, LOPERAMIDE, SKENAN, TEGRETOL, TIORFAN. Patient was hospitalized. Patient recovered.

Ask Our Patient Community about MEDROL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate

Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer